News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Welgus Howard G.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 8,500 shares
@ $13.7241, valued at
$116.7k
Exercised 8,500 options to buy
@ $1.68, valued at
$14.3k
|
|
| 11/17/2022 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 3,403 shares
@ $20.0125, valued at
$68.1k
Exercised 1,020 options to buy
@ $1.68, valued at
$1.7k
|
|
| 10/06/2022 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 6,000 shares
@ $20.2944, valued at
$121.8k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $20.4448, valued at
$51.1k
Exercised 1,496 options to buy
@ $0.5802, valued at
$868
Exercised 1,004 options to buy
@ $1.6806, valued at
$1.7k
|
|
| 04/01/2022 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 7,500 shares
@ $20.0245, valued at
$150.2k
Exercised 7,500 options to buy
@ $0.5802, valued at
$4.4k
|
|
| 01/05/2022 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $21.2118, valued at
$53k
Exercised 2,500 options to buy
@ $0.5802, valued at
$1.5k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $21.8096, valued at
$54.5k
Exercised 2,500 options to buy
@ $0.5802, valued at
$1.5k
|
|
| 10/05/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $23.8719, valued at
$59.7k
Exercised 2,500 options to buy
@ $0.5802, valued at
$1.5k
|
|
| 09/03/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 4,200 shares
@ $20.7063, valued at
$87k
Sold 800 shares
@ $21.275, valued at
$17k
Exercised 556 options to buy
@ $0.5802, valued at
$322.6
Exercised 4,444 options to buy
@ $1.6806, valued at
$7.5k
|
|
| 07/23/2021 |
4/A
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc. |
| 07/23/2021 |
4/A
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc. |
| 07/23/2021 |
4/A
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc. |
| 07/23/2021 |
4/A
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc. |
| 07/23/2021 |
4/A
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc. |
| 07/23/2021 |
4/A
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc. |
| 07/06/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,950 shares
@ $26.0294, valued at
$50.8k
Sold 250 shares
@ $26.874, valued at
$6.7k
Exercised 391 options to buy
@ $1.6806, valued at
$657.1
Exercised 781 options to buy
@ $1.6806, valued at
$1.3k
Exercised 1,028 options to buy
@ $6.522, valued at
$6.7k
|
|
| 06/11/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 13,391 options to buy
@ $27.77, valued at
$371.9k
|
|
| 06/03/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,058 shares
@ $27.0566, valued at
$55.7k
Sold 142 shares
@ $27.6072, valued at
$3.9k
Exercised 390 options to buy
@ $1.6806, valued at
$655.4
Exercised 781 options to buy
@ $1.6806, valued at
$1.3k
Exercised 1,029 options to buy
@ $6.522, valued at
$6.7k
|
|
| 05/25/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Exercised 390 options to buy
@ $1.6806, valued at
$655.4
Exercised 1,222 options to buy
@ $0.5802, valued at
$709 |
|
| 05/05/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,283 shares
@ $34.5586, valued at
$44.3k
Sold 917 shares
@ $35.124, valued at
$32.2k
Exercised 391 options to buy
@ $1.6806, valued at
$657.1
Exercised 781 options to buy
@ $1.6806, valued at
$1.3k
Exercised 1,028 options to buy
@ $6.522, valued at
$6.7k
|
|
| 04/20/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Exercised 391 options to buy
@ $1.6806, valued at
$657.1
Exercised 1,042 options to buy
@ $1.6806, valued at
$1.8k
Exercised 1,222 options to buy
@ $0.5802, valued at
$709 |
|
| 04/05/2021 |
4
| Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,160 shares
@ $29.2544, valued at
$33.9k
Sold 1,040 shares
@ $29.7549, valued at
$30.9k
Exercised 390 options to buy
@ $1.6806, valued at
$655.4
Exercised 781 options to buy
@ $1.6806, valued at
$1.3k
Exercised 1,029 options to buy
@ $6.522, valued at
$6.7k
|
|
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|